7 a.m.-8:30 a.m.
Industry-Supported Breakfast Symposium
IS40. Clinical Challenges in Anxiety (Part 1)Supported by Pfizer Inc.
A. Anxiety Disorders: Moving From Better to Well Mark H. Pollack, M.D.
B. Innovative Pharmacological Approaches to Treatment-Resistant Anxiety Disorders James W. Jefferson, M.D.
C. Novel Anxiolytics in Development and Abroad Stuart A. Montgomery , M.D.
IS41. A New Era for Managing Psychosis: Rebuilding Lives for Patients and Families (Part 1)Supported by Janssen Pharmaceutica
A. Integrating Pharmacological and Psychosocial Treatments: Improving Social and Vocational Outcomes Stephen R. Marder, M.D.
B. The Treatment of Juvenile-Onset Psychosis Patrick D. McGorry, Ph.D.
C. The Older Patient and Family Soo Borson, M.D.
IS42. Treatment of Depression in Women: From Acute Remission to Sustained Recovery (Part 1)Supported by Wyeth-Ayerst Laboratories
A. PMDD: How It Affects Women’s Lives Kimberly A. Yonkers, M.D.
B. Postpartum Depression: From Acute Treatment Response to Functional Recovery Lee S. Cohen, M.D.
C. Sex-Based Differences in Mood and Anxiety Disorders Adele C. Viguera, M.D.
IS43. Depression: Gender, Age, and Special Populations (Part 1)Supported by Eli Lilly and Company
A. Mood Disorders in the Child and Adolescent Graham J. Emslie, M.D.
B. Ethnic and Gender Issues in the Treatment of Depression David L. Dunner, M.D.
C. The Elderly Patient: A Delicate Balance Alan P. Siegal , M.D.
7:30 a.m.-5 p.m.
Registration/Course Enrollment Open
CME Courses 79-87
9 a.m.-10:30 a.m.
Clinical Case Conferences
3. Geoffrey M. Gabriel, M.D., on Vocal Cord Dyskinesia: A Dynamic Interchange Between Medicine and Psychiatry (Open to APA members only.)
4. Kathy L. Coffman, M.D., on Assessment of Prognostic Factors in the Alcoholic Patient (Open to APA members only.)
14. Ellen Leibenluft, M.D., on Bipolar Disorder in Children and Adults: Clinical and Research Issues
15. Vivien K. Burt, M.D., on Career Opportunities in Women’s Mental Health (For residents only)
16. Carl C. Bell, M.D., on Administrative Psychiatry: Leaderless Leadership
17. James L. Levenson, M.D., on Psychiatric Drugs in the Medically Ill
L15. How Matter Becomes Imagination: From Brain Dynamics to Consciousness:Gerald M. Edelman, M.D., Frontiers of Science Lecture Series
L16. Surviving Organizational Change Steven M. Mirin, M.D., APA’s Administrative Psychiatry Award Lecture
L17. Psychiatric Diagnosis: Are We Prepared for a New Millennium?Steven E. Hyman, M.D., APA’s Adolf Meyer Award Lecture
Master Education Clinical Consultations
12. Kathryn J. Zerbe, M.D., on Psychotherapy for Women (Open to APA members only.)
13. Paul R. McHugh, M.D., on Treatments Based on the Perspectives of Psychiatry (Open to APA members only.)
14. Troy L. Thompson II, M.D., on Depression, Antidepressants, and Sexual Dysfunction: Differential Diagnosis, Avoiding, Treating (Open to APA members only.)
CW33. Developing a Statewide Psychiatric Disaster Plan APA Committee on Psychiatric Dimensions of Disasters Chairperson: Sheila G. Jowsey, M.D.
CW34. Transgender Issues: Female to Male APA Northern California Psychiatric Society’s Committee on Lesbian, Gay, Bisexual, and Transgender Issues Chairperson: Dan H. Karasic, M.D.
CW35. Using Practice Guidelines in Residency Training APA Steering Committee on Practice Guidelines Chairperson: John S. McIntyre, M.D.
CW36. Psychiatry in the Neuroscience Curriculum: Promise and Peril APA Committee on Medical Student Education Chairperson: Carl B. Greiner, M.D.
CW37. Mind, Brain, and Environment: How Can Clinicians Address Social Ills? APA Committee on Poverty, Homelessness, and Psychiatric Disorders Chairperson: Hunter L. McQuistion, M.D.
CW38. Career Change for Psychiatrists and Patients Young and Old APA Committee on Psychiatry in the Workplace Chairperson: Harry Prosen, M.D.
IW60. Spiritual/Religious Assessment in Clinical WorkCo-Chairpersons: Francis G. Lu, M.D., and Christina M. Puchalski, M.D.
IW61. Homeopathic Medicine and PsychiatryChairperson: Edward B. Gogek, M.D.
IW62. Treating Physicians: Cutting-Edge IssuesChairperson: Michael F. Myers, M.D.
IW63. Psychodynamics in Treatment-Refractory DepressionCo-Chairpersons: Eric M. Plakun, M.D., and Edward R. Shapiro, M.D.
IW64. Nature and Nurture: Developing Comprehensive Services for Young ChildrenChairperson: Peter D. Ganime, M.D.
IW65. Crisis-Stabilization Units: Alternative to Hospital or de facto Hospital?Chairperson: Neil D. Price, M.D.
IW66. Treating Haredi (Very Orthodox) Jews in the United States and Israel The Mesorah Society for Traditional Judaism and Psychiatry Chairperson: Abba E. Borowich, M.D.
IW67. A Review of Patient Assaults on StaffCo-Chairpersons: Brandon Z. Erdos, M.D., and Douglas H. Hughes, M.D.
IW68. Spiritual Struggles: The New Priority in TreatmentCo-Chairpersons: Stephen M. Soltys, M.D., and Larry R. Wagner, Ph.D.
IW69. What Ever Happened to Psychotherapy?Chairperson: Edmundo J. Ruiz, M.D.
IW70. Working With Small BusinessesCo-Chairpersons: R. Mark Webb, M.D., and Melissa M. Hankins, M.D.
IW71. Educating Patients and Families About ECTChairperson: Harold A. Sacheim, Ph.D.
IW72. Do I Need an MBA to Transform My Career?Chairperson: Arthur L. Lazarus, M.D.
IW73. Distance-Learning OptionsCo-Chairpersons: Howard J. Osofsky, M.D., and Paul M. Balson, M.D.
IW74. Marijuana and Psychiatry: Dilemmas for the ClinicianChairperson: David H. Friar, M.D.
IW75. How to Detect DeceptionChairperson: Alan R. Hirsch, M.D.
IW76. Mid-Career Psychiatry: Staying Fresh and CreativeChairperson: Joel Yager, M.D.
IW77. Current and Future Trends in Psychiatry and Criminal LawChairperson: Michael M. Welner, M.D.
IW78. Using Hamlet to Learn About Teaching, Interviewing, and Therapeutic InteractionChairperson: Dinko Podrug, M.D.
IW79. International Problems With Personality Disorders in the WorkplaceCo-Chairpersons: James H. Reich, M.D., and Giovanni de Girolamo, M.D.
IW80. For Better or for Worse: Spouses of Patients With DementiaChairperson: Sheila M. Loboprabhu, M.D.
IW81. Does Johnny Need Methylphenidate?Chairperson: Antonio J. Gracia, M.D.
IW82. Treating PTSD Complicated by Medical Problems: Mind and Brain Meet BodyCo-Chairpersons: Gordon D. Strauss, M.D., and Michelle A. Fiorella, D.O.
IW83. Training IMG Residents: Challenges and OpportunitiesCo-Chairpersons: Nalini V. Juthani, M.D., and Richard Balon, M.D.
IW84. Neuroimaging: Integrating Bioethics With Clinical and Basic SciencesChairperson: Igor Elman, M.D.
IW85. Implementing Multidisciplinary Diagnosis and Management of PseudoseizuresCo-Chairpersons: Martin A. Goldstein, M.D., and Cynthia L. Harden, M.D.
IW86. Beyond Reductionism: Clinical ImplicationsChairperson: Ian E. Alger, M.D.
9 a.m.-11 a.m.
Session 19. Pain in Childhood: Body and Mind
31. No Fears. . . No Tears
32. In Grandma’s Hands
Session 20. When the Brain Hiccups
33. Twitch and Shout
Session 3. Digital Effects: Technology in the Clinical Practice
8. The Impact of Electronic Psychiatric Records on Patients and the Doctor-Patient Relationship
9. Digital Phenomenology of Depression
10. Using Virtual Reality to Treat Acrophobia
11. Internet Algorithms for the Pharmacotherapy of Depression: Java Version
9 a.m.-12:30 p.m.
Review of Psychiatry, Part IV: Brain Imaging in the New MillenniumChairperson: John M. Morihisa, M.D.
16. Future Applications for fMRI in Psychiatry Joseph H. Callicott III, M.D.
17. Imaging Human Cognition and Cognitive Disability in Mental Disorders Cameron S. Carter, M.D.
18. Structural and Functional Imaging in Late-Life Depression Harold A. Sackeim, Ph.D.
19. Neuroimaging Studies in Children: Implications for Research on Affect Daniel S. Pine, M.D.
20. Neuroimaging Abnormalities in Primary Mood Disorder Wayne C. Drevets, M.D.
9 a.m.-4 p.m.
CME Courses 88-90
10 a.m.-3 p.m.
Exhibits Open (last day)
Publishers’ Bookfair Open (last day)
APA Resource Center Open (last day)
11 a.m.-12:30 p.m.
18. Richard J. Frances, M.D., on Treating Addicted Patients With Psychiatric Comorbidity
19. Ann R. Turkel, M.D., on Medicine, Marriage, and Motherhood
20. Joel J. Wallack, M.D., on Psychiatry at the Medical Interface: Opportunities in the New Millennium
21. Randall D. Marshall, M.D., on Integrating Pharmacotherapy and Psychotherapy in PTSD
L18. Consciousness Integrated and Differentiated Giulio Tononi, M.D., Frontiers of Science Lecture Series
L19. Quills: The Marquis on the MarqueeDoug Wright
15. Ronald O. Rieder, M.D., on Teaching Psychopathology to Medical Students (AADPRT Council on Education Master Teacher) (Open to APA members only.)
16. Susan Lieff, M.D., on The Agitated Geriatric Patient (Open to APA members only.)
17. Francis G. Lu, M.D., on Cultural Issues in Clinical Case Formulation (Open to APA members only.)
Session 21. Aging Brains, Fading Minds
35. Choices and Challenge: Caring for Aggressive Adults
36. Something Should Be Done About Grandma Ruthie
Session 22. Between Sanity and Insanity: A Fragile Boundary
37. Through Madness
38. Between the Lines
Medical Update 3.Donna H. Ryan, M.D., on Will Medicalizing Obesity Treatment Improve Outcomes?
Research Consultation 2.David Shaffer, M.D., on Youth Suicide Research
Scientific and Clinical Report Sessions
Session 23. Depression Across Cultures
68. Depression in Chinese Primary Care Patients L.K. George Hsu, M.D.
69. Illness Beliefs of Depressed Chinese Americans in Primary Care Albert Yeung, M.D.
70. Depression in College Students in Bombay Rajesh M. Parikh, M.D.
Session 24. Psychotherapy Issues
71. A 45-Year Experience With OCD Patients Who Fear Harming Someone or Fear Harm or Humiliation to Themselves Albert H. Schrut, M.D.
72. Solving the Riddle of Working Through in Psychotherapy Steven H. Lipsius, M.D.
73. Telepsychiatry for Suicidal Outpatients: Lower Morbidity, Mortality, and Cost Ann M. Oberkirch, M.D.
Session 25. Risk Factors in Suicide
74. Suicide Mortality in the Ukraine in 1999 Ludmila Kryzhanovskaya, Ph.D.
75. Decreasing Suicide Mortality in Hungary: What Are the Main Causes? Zoltan Rihmer, M.D.
76. Suicide Risk Factors Among Treated Patients With BPD Thomas M. Kelly, Ph.D.
Session 26. Ethics and Justice
77. Willingness and Competence of Depressed Inpatients to Consent to Research Bruce J. Cohen, M.D.
78. Arthur Kronfeld: Professional and Personal Tragedy of a Great Psychiatrist Elena B. Bezzubova, M.D.
79. False Confessions: The Bane of Criminal Justice Hanus J. Grosz, M.D.
Session 27. Issues in Violence and Trauma
80. Violence and Clinical Symptoms in Different Diagnoses Menahem Krakowski, M.D.
81. Posttraumatic Spectrum Disorders: A Radical Revision of PTSD K. Elan Jung, M.D.
82. Open Study of Nefazodone in Depression With Anger Attacks David Mischoulon, M.D.
Session 28. Psychopharmacology and Child and Adolescent Psychiatry
83. Adderall and Methylphenidate in ADHD Stephen V. Faraone, Ph.D.
84. Comparison of Duration of Effect of OROS MPH With MPH TID in ADHD Children Sharon Wigal, Ph.D.
85. Once-Daily-Dosed SLI381 for Pediatric ADHD Joseph Biederman, M.D.
Session 29. Depression
86. The Response of Psychotic-Like Symptoms to Fluoxetine in Nonpsychotic MDD Christina M. Dording, M.D.
87. Predictors of Stable Personality Disorders in Remitted Depressed Outpatients Amy Farabaugh, M.A.
88. Personality Disorders in Psychotic Major Depression John D. Matthews, M.D.
Session 30. International Perspectives on Psychiatry
89. Lifetime and 12-Month Prevalence of Mental Illness in Chile Benjamin Vicente, M.D.
90. Race and Psychiatry in Post-Apartheid South Africa Christopher P. Szabo, M.D.
91. The World Psychiatric Association: An International Survey of Urban Mental Health Giovanni Caracci, M.D.
Session 31. Social and Community Psychiatry
92. Mental Health and Stress in Highly Educated Employees Cheryl Koopman, Ph.D.
93. The Next Step Group: Multimodal Strategies in Group Therapy for Serious Illness Victor McGregor, Ph.D.
94. Psychiatric Issues in Space: Implications From the Space Shuttle/MIR Program Nick A. Kanas, M.D.
Session 32. Issues in the Treatment of Mood Disorders
95. Olanzapine Versus Divalproex Sodium for the Treatment of Acute Mania Mauricio F. Tohen, M.D.
96. Risk of Postpartum Depression in Women With Pregravid Major Depression Disorder Ruta M. Nonacs, M.D.
97. The Rising Prevalence of Antidepressant Treatment for U.S. Youth Julie M. Zito, Ph.D.
CW39. Career Choices in Psychiatry APA Assembly Committee of Area Member-in-Training Representatives Co-Chairpersons: Mary Ann Schaepper, M.D., and Cathryn A. Galanter, M.D.
CW40. New Regulatory Requirements for Seclusion and Restraints APA Committee on Standards and Survey Procedures Chairperson: Charles E. Riordan, M.D.
CW41. How to Enhance Motivation in Patients With Substance Abuse Problems APA Committee on Training and Education in Addiction Psychiatry and American Academy of Addiction Psychiatry Co-Chairpersons: Jonathan I. Ritvo, M.D., and Richard S. Schottenfeld, M.D.
CW42. A Collaborative Effort to Define and Measure Psychiatric Competencies APA Council on Medical Education and Career Development Chairperson: Nyapati R. Rao, M.D.
CW43. Hispanics and Alternative Medicine APA Committee of Hispanic Psychiatrists Chairperson: Oscar E. Perez, M.D.
CW44. Successful Models of Psychiatric Care in the Nursing Home APA Committee on Long-Term Care and Treatment for the Elderly and APA Committee on Access and Effectiveness of Psychiatric Services for the Elderly Chairperson: Deborah A. Banazak, D.O.
CW45. The Administrative Psychiatry Credential APA Committee on Psychiatric Administration and Management Co-Chairpersons: William H. Reid, M.D., and W. Walter Menninger, M.D.
IW87. Psychiatric Illness in Psychiatrists: Overcoming Stigma National Alliance for the Mentally Ill Co-Chairpersons: Michael F. Myers, M.D., and Leah J. Dickstein, M.D.
IW88. The Portrayal of Psychiatry in Recent American FilmChairperson: Steven E. Pflanz, M.D.
IW89. Making the Media Work for YouChairperson: Nada L. Stotland, M.D.
IW90. Comparative Efficacy of Antidepressants and Psychotherapy for DepressionChairperson: Sidney L. Werkman, M.D.
IW91. Private Practice and the World Psychiatric AssociationChairperson: Michael C. Hughes, M.D.
IW92. Update on the Practice Guideline on BPDChairperson: John M. Oldham, M.D.
IW93. Foundation of the World Federation of Psychiatric TraineesCo-Chairpersons: Victor J.A. Buwalda, M.D., and Michelle Riba, M.D.
IW94. Eight-Day Treatment of Panic With Moderate to Severe AgoraphobiaChairperson: David A. Spiegel, M.D.
IW95. Mind Meets Brain in Family Therapy: Bridges for HealingChairperson: Roy O. Resnikoff, M.D.
IW96. Confidentiality and Sexual History Issues in Sexual Harassment CasesChairperson: Rita R. Newman, M.D.
New Research Poster Session 8
12:30 p.m.-2 p.m.
Session 23. Loss and Grief: Three Perspectives
39. Fighting Grandpa
40. Men Like My Father, Families Like My Own
41. What Do I Tell My Children?
1 p.m.-5 p.m.
CME Courses 91-94
2 p.m.-3:30 p.m.
L20. The Science of Psychotherapy Legacy of Psychoanalysis:Leo Rangell, M.D. Distinguished Psychiatrist Lecture Series
L21. Psychiatry for the Medically Ill: What Is It? What Was It? What Has It Done?Donald S. Kornfeld, M.D., Distinguished Psychiatrist Lecture Series
2 p.m.-5 p.m.
Session 24. Youth and Violence
42. Generations of Violence
43. Colors Straight Up
Session 25. When Development Goes Awry
44. Come Back Jack
45. Autism: A World Apart
46. A Dyslexic Family Diary
S64. Findings From Multisite Collaborative Longitudinal Study of Personality
A. Confirmatory Factor Analysis of the DSM-IV BPD Criteria Charles A. Sanislow, Ph.D.
B. A Schedule for Nonadaptive and Adaptive Personality: Dimensional Representation of Four Personality Disorders Leslie C. Morey, Ph.D.
C. 12-Month Remission of Major Depressive Disorder: Influence of Personality Disorders Carlos M. Grilo, Ph.D.
D. Graphical Methods for Dynamic Relationships Between Axis I and Axis II Disorders Robert L. Stout, Ph.D.
E. Early Remissions in Borderline Patients John G. Gunderson, M.D.
S65. Update on Deficit Schizophrenia
A. The Italian Multicenter Study of Deficit Schizophrenia Silvana Galderisi, M.D.
B. The Treatment of Negative Symptoms Donald C. Goff, M.D.
C. Family Studies of Eye Tracking and the Heterogeneity of Schizophrenia Dolores Malaspina, M.D.
D. Course of Illness in Deficit Schizophrenia Cenk Tek, M.D.
E. A Separate Disease Within the Syndrome of Schizophrenia Brian Kirkpatrick, M.D.
S66. Women’s Resiliency to Adversity
A. A Prospective Study of Depression in Pregnant Women: Risk Factors Related to Postpartum Relapse Shaila Misri, M.D.
B. Stalking: An Overview of the Problem Gail E. Robinson, M.D.
C. Attachment, Abuse, and Psychopathology Risk: Human Papillomavirus Susanne I. Steinberg, M.D.
D. Attributions of Cause and Recurrence in Long-Term Breast Cancer Survivors Donna E. Stewart, M.D.
E. Challenges for Women in Academic Medicine Katherine L. Wisner, M.D.
S67. Clinical Issues and Ethical Concerns Regarding Attempts to Change Sexual Orientation: An UpdateAssociation of Gay and Lesbian Psychiatrists and APA Committee on Gay, Lesbian, and Bisexual Issues
A. Overview of the Research Problems and Ethics of Therapy to Change Sexual Orientation Marshall Forstein, M.D.
B. Subjects Who Claim to Have Benefited From Sexual Reorientation Therapy Robert L. Spitzer, M.D.
C. Clinical and Religious Attempts to Change Homosexual Orientations: An Empirical Study Ariel Shidlo, Ph.D.
D. Ethical Issues in Efforts to Ban Reorientation Therapies Mark Yarhouse, Psy.D.
E. Ethical Concerns Raised When Patients Seek to Change Same-Sex Attractions Jack Drescher, M.D.
S68. State Versus Trait Disturbances Found in Eating Disorders: Recent Findings
A. 5HT Function in Women With Anorexia Nervosa Evelyn Attia, M.D.
B. Resting Energy Metabolism in Anorexia Nervosa Laurel Mayer, M.D.
C. Psychobiological Studies of Women With Bulimia Nervosa B. Timothy Walsh, M.D.
D. Eating Behavior in Binge Eating Disorder: Implications for Treatment Michael J. Devlin, M.D.
S69. Model Residency Programs on Religion and Spirituality
A. Psychiatric Residency Training on Religion/Spirituality: An Overview Francis G. Lu, M.D.
B. The Emory Spirituality, Religion, and Culture in Child and Adolescent Psychiatry Curriculum Sandra Sexson, M.D.
C. The University of Alabama Curriculum on Religion, Spirituality, and Psychiatry Nathan B. Smith, M.D.
D. Expectable and Surprising Consequences of Templeton Award: A Three-Year Follow-Up at Baylor James W. Lomax II, M.D.
S70. Psychopathological Pathways Following Traumatic Life Experience
A. Multiple Comorbidities or Trauma-Spectrum Disorders in the U.S. National Comorbidity Survey Joseph F. Spinazzola, Ph.D.
B. Traumatic Stress as an Antecedent to Psychotic Disorder Alexander McFarlane, M.D.
C. Simple and Complex PTSD Among the Dually Diagnosed Walter E. Penk, Ph.D.
D. Trauma, PTSD, and Disorders of Extreme Stress in Women With Severe Mental Illness Julian Ford, Ph.D.
S71. The World Psychiatric Association Global Program to Reduce the Stigma of SchizophreniaThe World Psychiatric Association
A. The German Program Wolfgang Gaebel, M.D.
B. World Psychiatric Association Antistigma Project: The Campaign in Canada Julio E. Arboleda-Florez, M.D.
C. The Campaign in Spain Juan J. Lopez-Ibor Jr., M.D.
D. The Campaign in Egypt: Development, Activities, and Achievements Mohamed H. El Defrawi
E. The Campaign in India Srinivasa Murthy, M.D.
S72. European Perspectives on the Biology of Personality DisordersInternational Society for the Study of Personality Disorders
A. Childhood Abuse and the HPA Axis in Adult Female Patients Thomas Rinne, M.D.
B. Dimensional Psychobiological Studies in BPD Jose L. Carrasco, M.D.
C. Studies on Temperament Markers on Eating Disorders Marina Diaz-Marsa, M.D.
D. Schizotypy: A Genetic, Epidemiological, and Developmental Perspective Marco Battaglia, M.D.
E. Serotonergic and Cognitive Impairment in Personality-Disordered Offenders Mairead Dolan, Ph.D.
S73. An Eight-Week Randomized Trial of Fluvoxamine for Pediatric Anxiety Disorder
A. Background and Significance of the Research Units of Pediatric Psychopharmacology (RUPP) Pediatric Anxiety Disorder Trial of Fluvoxamine Laurence L. Greenhill, M.D.
B. Moderators and Mediators of Treatment Effect in the RUPP Pediatric Anxiety Disorder Trial of Fluvoxamine Benedetto Vitiello, M.D.
C. Data From the Intent-to-Treat Data Analysis: RUPP Pediatric Anxiety Disorder Trial of Fluvoxamine Daniel S. Pine, M.D.
D. Use of the Pediatric Anxiety Rating Scale in the RUPP Pediatric Anxiety Disorder Trial of Fluvoxamine John T. Walkup, M.D.
S74. Psychiatric Management in Neurological Disease
A. Psychiatric Aspects of Parkinson’s Disease Matthew A. Menza, M.D.
B. Psychiatric Management in Huntington’s Disease Neal G. Ranen , M.D.
C. Psychiatric Management in Wilson’s Disease Edward C. Lauterbach, M.D.
D. Psychiatric Management of Stroke Robert G. Robinson, M.D.
E. Psychiatric Management in Multiple Sclerosis Randolph B. Schiffer , M.D.
F. Neuropsychiatric Aspects of AIDS Francisco Fernandez, M.D.
S75. Critical Issues in Early Intervention of the Psychosis Prodrome
A. Early Detection by Screening Relatives of Schizophrenic Patients Scott W. Woods, M.D.
B. Diagnosing and Rating the Psychosis Prodrome Tandy J. Miller, Ph.D.
C. Psychosis Prodrome, Conversion, and Neuropsychological Course Keith A. Hawkins, Psy.D.
D. Medication Prescribed by Community Providers for Patients in Schizophrenic Prodromal States Adrian Preda, M.D.
E. Short-Term Outcome of Prodromal Patients Treated at Conversion to Psychosis Joanna Rosen, Ph.D.
F. Ethical Issues in the Pre-Onset Treatment of Schizophrenia Thomas H. McGlashan, M.D.
S76. Mind/Brain, Reduction, and Schizophrenia
A. Understanding Anxiety: Conceptual, Clinical, and Neuroscientific Considerations Gerrit Glas, M.D.
B. Mind and Brain in Schizophrenia: Two Sides of the Same Coin? Aaron L. Mishara, Ph.D.
C. Ontological Reduction and Integration in Psychiatric Genetics Research John Z. Sadler, M.D.
D. The Cognitive Neuropsychiatry of Disorders of Will and Volition Sean A. Spence, M.D.
S77. Childhood-Onset Depression: A Multigenerational Multidisciplinary Study
A. Risk Factors for Childhood-Onset Depression: Understanding and Treatment Maria Kovacs, Ph.D.
B. Molecular Genetic Studies of Childhood-Onset Depression James L. Kennedy, M.D.
C. EEG Asymmetry and Vagal Tone in Childhood-Onset Depression: Probands and Offspring Nathan A. Fox, Ph.D.
D. Parenting Risk Factors Among Offspring of Childhood-Onset Depressed Mothers Daniel Shaw, Ph.D.
S78. Psychiatric Disturbances in Parkinson’s Disease: Recognition and Management
A. Multidisciplinary Management of Psychiatric Manifestations of Parkinson’s Disease Melanie Brandabur, M.D.
B. Treatment of Depressive Disorders in Patients With Parkinson’s Disease F. Moises Gaviria, M.D.
C. Managing Psychotic Symptoms in Parkinson’s Disease David A. Medina, M.D.
D. Functional Neuroimaging and Neurobiological Correlates of Cognitive Impairment in Patients With Parkinson’s Disease Glenn T. Stebbins, Ph.D.
S79. Psychobiology and Pharmacotherapy of BPD
A. Biological Correlates of BPD Emil F. Coccaro, M.D.
B. Psychobiology of Human Personality C. Robert Cloninger, M.D.
C. Longitudinal Patterns of Medication Utilization in BPD John M. Oldham, M.D.
D. Pharmacotherapy of BPD Paul H. Soloff, M.D.
E. Clinical Management of Suicidality in BPD Maria A. Oquendo, M.D.
S80. Special Topics in Women’s Mental Health
A. Alcoholism and Drug Abuse in Women Monica L. Zilberman, Ph.D.
B. Pathological Gambling in Women Hermano Tavares, Ph.D.
C. The Role of Estrogen in Perimenopausal Depression Claudio N. Soares, M.D.
D. Comorbid Depression and Anxiety Disorders in Couples Presenting for In Vitro Fertilization Rajesh M. Parikh, M.D.
S81. The Role of Religion in the Lives of Our Patients: Clinical Approaches
A. Religion as a Framework in Understanding and Responding to Mental Illness Irving S. Wiesner, M.D.
B. The Role of Religion in the Lives of Our Patients: A Hindu Approach Nalini V. Juthani, M.D.
C. The Special Needs of the Orthodox Jewish Patient Abba E. Borowich, M.D.
D. Personhood and the Pursuit of Happiness: A Catholic Perspective Judith A. Hughes, M.D.
E. Clinical Challenges With Protestant Patients: Sin, Guilt, and Forgiveness Mark E. Servis, M.D.
S82. Update on Treatment of Stimulant Abuse
A. Recovery-Oriented Psychosocial Treatments Douglas M. Ziedonis, M.D.
B. Psychotherapy and Counseling Approaches for Cocaine Abuse Treatment David R. Gastfriend, M.D.
C. Pharmacological Treatment of Stimulant Abuse David A. Gorelick, M.D.
D. Psychiatric Comorbidity in Stimulant Abusers Richard N. Rosenthal, M.D.
E. Methamphetamine Abuse: Update 2001 Steven L. Batki, M.D.
S83. Politics of Administrative Relationships in Psychiatry
A. Defining Administrative Roles: Divide and Cooperate Clifton R. Tennison Jr., M.D.
B. Developing Relationships and Enhancing Roles in a Managed Care Organization William G. Wood, M.D.
C. Psychiatrist/Administrator Alliances in Public Psychiatry Thomas A. Simpatico, M.D.
D. Navigating in Rough Water: When It Doesn’t Work Gordon H. Clark Jr., M.D.
E. The Value of Medical Leadership: More Than a Dream? Kathleen A. Daly, M.D.
S84. Outreach to Business:The American Psychiatric Association Business Initiative, APA Committee on APA/Business Relationships
A. Quality Mental Health Care and the Corporate Bottom Line Norman A. Clemens, M.D.
B. Organizations and Their Impact on Productivity and Health Leonard T. Sperry, M.D.
C. Helping Business to Understand Psychiatric Skills Marcia K. Goin, M.D.
D. Patients’ Workplace Lives: Career, Performance, and Development Jeffrey P. Kahn, M.D.
E. Special Concerns of Business Conflict Management, Disability, Violence, and Employee Turnover Stephen H. Heidel, M.D.
S85. Quality of Life in Patients With Schizophrenia: Research in Europe and the Americas
A. Quality of Life: History and Development in the U.S. Anthony F. Lehman, M.D.
B. The Definition and Evaluation of Quality of Life Pierre Lalonde, M.D.
C. Schizophrenia and Quality of Life Across Europe Viviane Kovess, M.D.
D. Quality of Life for Patients With Schizophrenia Treated in Day Hospitals Francois C. Petitjean, M.D.
E. Quality of Life in Schizophrenia: A Two-Year Follow-Up Study of 145 Outpatients Oliver J. Canceil, M.D.
F. Quality-Adjusted Life Year (QALY) Measurement in Persons With Schizophrenia Jeffrey M. Pyne, M.D.
S86. Catatonia and NMS: Past, Present, and Future
A. Development of the Concept of Catatonia: A Historical Overview Stephanie Kruger, M.D.
B. The Nosology of Catatonia Gabor S. Ungvari, M.D.
C. Laboratory Findings in Catatonia Joseph W. Lee, M.D.
D. Catatonia in the Context of Medical Illness Brendan T. Carroll, M.D.
E. NMS and Other Drug-Induced Catatonias Andrew J. Francis, M.D.
S87. Advance Directives in Psychiatry: Treatment Research and End of Life
A. Psychiatric Advance Directives: An Emerging Form of Psychosocial Intervention? Patricia Backlar, Ph.D.
B. Research Advance Directives in Psychiatry Donald L. Rosenstein, M.D.
C. End-of-Life Care and Mental Illness: A Model for all Disciplines Philip J. Candilis, M.D.
D. Cognitive Variables in the Informed-Consent Assessment Process Jacob C. Holzer, M.D.
S88. Psychocutaneous Medicine
A. Introduction: Overview and Classification System for Psychocutaneous Disease Donald J. Kushon Jr., M.D.
B. Stress and Cutaneous Biology Francisco Tausk, M.D.
C. Pruritus: Psychogenic and Central Factors Iona Ginsberg, M.D.
D. Treatment of Self-Mutilation Sylvia G. Garnis-Jones, M.D.
E. Integration of Psychotherapy and Psychoanalysis Into Dermatology Practice Caroline S. Koblenzer, M.D.
F. Psychopharmacology Donald J. Kushon Jr., M.D.
G. Nonpharmacologic Management of Psychocutaneous Problems Richard G. Fried, M.D.
S89. The Use of Force in Psychiatry: When Is It Helpful and When Is It Not? Part IIAmerican Association of Community Psychiatrists
A. Seclusion and Restraint in Child and Adolescent Facilities Wanda Mohr, Ph.D.
B. Excessive Use of Force: The Family Perspective Andrea Eberle, M.D.
C. Seclusion, Restraint, and Holding of Children and Adolescents: A Clinical Community Perspective Charles W. Huffine Jr., M.D.
D. Use of Seclusion, Restraint, and Force in Juvenile Justice Settings Debbie R. Carter, M.D.
E. Managing and Treating Behavioral Dyscontrol in People With Developmental Disabilities Ruth M. Ryan, M.D.
F. Pharmacological Approaches: When Are They Indicated? Andres J. Pumariega, M.D.
Session 4. Digital Dangers: Sex, Suicide, and Addictions on the Web
12. Caught in the Web: Sex, Suicide, and Addictions on the Internet
2 p.m.-5:30 p.m.
Review of Psychiatry, Part V: Psychiatry Update: Somatoform and Factitious DisordersChairperson: Katharine A. Phillips, M.D.
21. BDD Katharine A. Phillips, M.D.
22. A Critical Analysis of Factitious Disorder Marc D. Feldman, M.D.
23. Somatization Disorder Vicenzio Holder-Perkins, M.D.
24. Conversion Disorder Jose R. Maldonado, M.D.
25. Hypochondriasis Brian A. Fallon, M.D.
3 p.m.-5 p.m.
New Research Poster Session 9
7 p.m.-10 p.m.
IS44. Plasticity as Efficacy? Neurotrophic Effects of Mood StabilizersSupported by Abbott Laboratories
A. Neurotrophic and Neuroprotective Effects of Mood Stabilizers Husseini K. Manji, M.D.
B. Clinical and Neuroimaging Evidence of Illness Progression in Bipolar Disorder Terence A. Ketter, M.D.
C. Implications for the Treatment of Alzheimer’s Disease Pierre N. Tariot, M.D.
D. PTSD, Substance Use Disorders, and Personality Disorders: Commonalties in Mechanisms and Treatment Hugh Myrick, M.D.
IS45. Bipolar Spectrum Disorders: U.S. and European PerspectivesSupported by the International Academy for Biomedical and Drug Research
A. Longitudinal Studies of Bipolar Disorders: Is There a Spectrum? Lewis L. Judd, M.D.
B. Bipolar Spectrum: Clinical and Familial Validation Hagop S. Akiskal, M.D.
C. Molecular Genetic Evidence for the Bipolar Spectrum Julien Mendlewicz, M.D.
D. Treatment Advances in Bipolar Spectrum Disorders: Mood Stabilizers Susan L. McElroy, M.D.
E. Treatment Advances in Bipolar Spectrum Disorders: Atypical Antipsychotics Guy M. Goodwin, M.D.
IS46. Advances in ADHD: Navigating ComorbiditySupported by Alza Corporation
A. Overview of Comorbid Conditions in ADHD Joseph Biederman, M.D.
B. Patterns of Comorbidity in ADHD: Artifact or Reality? Stephen V. Faraone, Ph.D.
C. Depressive Disorders and ADHD Thomas J. Spencer, M.D.
D. Bipolar Disorder and ADHD: An Overlooked Comorbidity Janet Wozniak, M.D.
E. ADHD and the Substance Use Disorders Timothy E. Wilens, M.D.
IS47. Excessive Daytime Sleepiness: Evaluation and Management in PsychiatrySupported by Cephalon Inc.
A. Neural Substrates of Arousal and Sleep: New Vistas Robert W. McCarley, M.D.
B. Evaluation and Measurement of Daytime Sleepiness Mary A. Carskadon, Ph.D.
C. Disorders of Excessive Daytime Somnolence: Diagnosis and Management Karl Doghramji, M.D.
D. Excessive Daytime Sleepiness in the Psychiatric Patient John W. Winkelman, M.D.
IS48. An Evidence-Based Medicine Approach to Pediatric PsychiatrySupported by Ortho-McNeil Pharmaceutical
A. Long-Term Efficacy in Conduct Disorder: Evidence From Maintenance Trials Robert L. Findling, M.D.
B. Effects of Risperidone on the Behavior of Children With Subaverage IQs and Conduct Disorder or Oppositional Defiant Disorder Michael G. Aman, Ph.D.
C. A Placebo-Controlled Trial of Risperidone in Tourette’s Disorder: Preliminary Results Lawerence D. Scahill, M.D.
D. Comparative Use of Olanzapine and Risperidone in Psychotic Youth Linmarie Sikich, M.D.
Session 26. Psychiatry Goes to the Movies
47. The Talented Mr. Ripley
Session 27. Psychiatry Goes to the Movies
48. 2001: A Space Odyssey ▪
Download citation file:
Please confirm that your email address is correct, so you can successfully receive this alert.